HQS Quantum Simulations

"Turns quantum physics into usable software for spectroscopy, moving teams from spectra and spin models to decisions with accuracy, speed, and interpretability." [1]

Where it wins

• HQSpectrum is the first full version of software for predicting and analyzing Nuclear Magnetic Resonance (NMR) spectra, designed to reduce manual effort and improve traceability. [1]
• The software runs on both current high-performance computing systems and can be seamlessly applied to quantum systems, offering a hybrid workflow. [2]
• HQSpectrum features a new structure elucidation workflow that allows users to compare predicted spectra against experimental data to identify the best-fitting molecular structure. [1]
• HQSpectrum offers a free trial for students and researchers to benchmark results against trusted classical baselines. [1]

Credibility: HQSpectrum release announcement and feature updates on the HQS website, TRUMPF Venture investment press release.

• Sells production-ready quantum simulation software that bridges classical high-performance computing and quantum hardware. [2]
• Delivers value through accurate, interpretable spectroscopic analysis that reduces manual effort in research workflows. [1]
• Scales via cloud-based software delivery (HQSpectrum, HQStage) and open-source quantum toolkits (qoqo, struqture). [3]
• Margin sits in software licensing and cloud usage fees, leveraging proprietary quantum simulation methods. [1]

• Classical spectroscopy software: HQS offers superior accuracy and quantum-enhanced analysis. [1]
• Quantum computing platforms: HQS provides specialized simulation software rather than hardware. [2]
• Academic research tools: HQS delivers production-ready, commercially supported software. [1]
• Other quantum simulation startups: HQS focuses specifically on spectroscopy and NMR. [4] Differentiators: HQS bridges classical and quantum computing with industry-ready workflows and strong academic partnerships.

• Manual, time-consuming molecular structure elucidation in chemistry and pharma R&D. [1]
• Limited accuracy and interpretability of classical spectroscopic analysis methods. [1]
• Difficulty integrating quantum simulation results into existing industrial workflows. [2]
• Lack of accessible tools for researchers to benchmark quantum advantage in spectroscopy. [1]
• Complexity of handling quantum noise and decoherence in near-term quantum computers. [4]

HQS is well-positioned to capture early enterprise value in quantum simulation by focusing on a high-impact, well-defined use case (NMR spectroscopy). The hybrid classical-quantum approach mitigates near-term hardware limitations while building customer workflows. The main risk is the timeline for quantum advantage; if classical methods improve faster, the value proposition weakens. The next signal to watch is the adoption rate of HQSpectrum in pharma and materials R&D, and progress on quantum hardware benchmarks via the ITBQ framework.

Expand marketing of HQSpectrum's specific ROI (time saved, accuracy improved) to pharma and materials companies to drive enterprise sales. Develop more structured pricing tiers and enterprise SLAs to convert trial users into paying customers. Leverage open-source toolkits (qoqo, struqture) to build a broader developer ecosystem and drive adoption of the HQS ecosystem. Pursue more industry-specific partnerships (e.g., with pharma companies) to co-develop use cases and validate quantum advantage claims.